NEW YORK, NY / ACCESSWIRE / August 12, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

TUP Shareholders Click Here: https://www.zlk.com/pslra-1/tupperware-brands-corporation-loss-submission-form?prid=30805&wire=1
YEXT Shareholders Click Here: https://www.zlk.com/pslra-1/yext-lawsuit?prid=30805&wire=1
OM Shareholders Click Here: https://www.zlk.com/pslra-1/outset-medical-inc-information-request-form?prid=30805&wire=1

* ADDITIONAL INFORMATION BELOW *

Tupperware Brands Corporation (NYSE:TUP)

TUP Lawsuit on behalf of: investors who purchased November 3, 2021 - May 3, 2022
Lead Plaintiff Deadline: August 15, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tupperware-brands-corporation-loss-submission-form?prid=30805&wire=1

According to the filed complaint, during the class period, Tupperware Brands Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Tupperware was facing significant challenges in maintaining its earnings and sales performance; (ii) accordingly, Tupperware's full-year 2022 guidance was unrealistic and/or unsustainable; (iii) all the foregoing, once revealed, was likely to have a material negative impact on Tupperware's financial condition; and (iv) as a result, the Company's public statements were materially false and
misleading at all relevant times.

Yext, Inc. (NYSE:YEXT)

YEXT Lawsuit on behalf of: investors who purchased March 4, 2021 - March 8, 2022
Lead Plaintiff Deadline: August 16, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/yext-lawsuit?prid=30805&wire=1

According to the filed complaint, during the class period, Yext, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Yext's revenue and earnings were significantly deteriorating because of, among other things, poor sales execution and performance, as well as COVID-19 related disruptions; (ii) accordingly, Yext was unlikely to meet consensus estimates for its full year fiscal 2022 financial results and fiscal 2023 outlook; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Outset Medical, Inc. (NASDAQ:OM)

This lawsuit is on behalf of all persons or entities who purchased Outset Medical common stock between September 15, 2020, and June 13, 2022.
Lead Plaintiff Deadline: September 6, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/outset-medical-inc-information-request-form?prid=30805&wire=1

According to the filed complaint, (1) the Company's flagship product, Tablo Hemodialysis System ('Tablo'), would require an additional 510(k) application to be filed with The United States Food and Drug Administration ('FDA'), as defendants had 'continuously made improvements and updates to Tablo over time since its original clearance' (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) the Company's inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a 'shipment hold' and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and /or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP